| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/04/2010 | US20100055202 Antiinfective free intramammary veterinary composition |
| 03/03/2010 | EP2158916A1 Administration unit comprising lactic acid bacteria |
| 03/03/2010 | EP2158914A2 Use of estriol in low doses |
| 03/03/2010 | EP2158907A2 A composition for use as a medicament for topical application to skin |
| 03/03/2010 | EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/03/2010 | EP1773796B1 Oxopiperidine derivatives, preparation and therapeutic use thereof |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/02/2010 | US7671091 Administering vasodilator in carrier or diluent |
| 03/02/2010 | US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 03/02/2010 | US7671027 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation |
| 03/02/2010 | US7670606 Method for administering a vaginal care composition |
| 03/02/2010 | CA2292836C Prostaglandin pharmaceutical compositions |
| 02/25/2010 | WO2010001258A3 Inhibition of tumour growth and metastases |
| 02/25/2010 | WO2009152344A3 Combination therapy using phosphodiesterase inhibitors |
| 02/25/2010 | US20100048711 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048523 Compounds, Compositions and Methods for Treating Hormone-Dependent Maladies |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN100591225C Composition containing isoflavone of high concentration and having high solubility, and process for producing the same |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666867 Heteroindanes: a new class of potent cannabimimetic ligands |
| 02/23/2010 | US7666858 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2442974C Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |
| 02/18/2010 | WO2010017614A1 Mucoadherents compositions and their use |
| 02/18/2010 | US20100041624 Buprenorphine formulations for intranasal delivery |
| 02/18/2010 | US20100040708 Herbal composition |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2733724A1 Mucoadherents compositions and their use |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2154147A1 A truncated l1 protein of human papillomavirus 16 |
| 02/17/2010 | EP2154139A1 Bicyclic heterocyclic compound |
| 02/17/2010 | EP2153849A2 Contraception process and administration form for the same |
| 02/17/2010 | EP2049092B1 Compositions with enhanced elasticizing activity |
| 02/17/2010 | EP1675603B9 Use of probiotic bacteria in the treatment of infection |
| 02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
| 02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/16/2010 | US7662825 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/16/2010 | US7662817 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | US7662380 ZAQ ligand-1 antibodies and uses thereof |
| 02/16/2010 | CA2528008C 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/16/2010 | CA2447175C Use of estrogen compounds to increase libido in women |
| 02/16/2010 | CA2440037C Benzimidazole derivatives for modulating the rage receptor |
| 02/16/2010 | CA2410399C 5-aminoalkylpyrazolo[4,3-d]pyrimidines |
| 02/16/2010 | CA2407043C Naphthamidine urokinase inhibitors |
| 02/16/2010 | CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 02/16/2010 | CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals |
| 02/16/2010 | CA2344435C Compositions for the treatment of male erectile dysfunction |
| 02/11/2010 | WO2010015972A1 Diazepine and diazocane compounds as mc4 agonists |
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015718A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 02/11/2010 | WO2010015589A1 Benzyl-substituted tetracyclic heterocyclic compounds as pde5 inhibitors |
| 02/11/2010 | WO2010015586A2 2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015585A1 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015372A1 Pregnancy prevention using gestagens |
| 02/11/2010 | WO2010015205A1 The use of sophoricoside in preparing medicaments |
| 02/11/2010 | US20100035994 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | DE102008036825A1 Schwangerschaftsvermeidung durch Gestagene Pregnancy prevention by progestins |
| 02/11/2010 | CA2732877A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 02/11/2010 | CA2731897A1 Diazepine and diazocane compounds as mc4 agonists |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/09/2010 | CA2483597C New pharmaceutical compositions containing flibanserin polymorph a |
| 02/09/2010 | CA2466720C Medicament for the treatment of viral skin and tumour diseases |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/04/2010 | WO2010013762A1 Metastin derivative and use thereof |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010013187A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2010012131A1 The usage of medicinal composition containing oil of zedoary turmeric in manufacture of medicaments |
| 02/04/2010 | WO2008132710A3 Pharmaceutical nimodipine compositions |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029671 Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders |
| 02/04/2010 | US20100029641 Aryl sulfamide derivatives and methods of their use |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029624 Male Contraceptive |
| 02/04/2010 | US20100029622 Microemulsions |
| 02/04/2010 | US20100029603 16alpha-methyl or ethyl substituted estrogens |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | DE20321786U1 Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D Combination preparation of oral contraceptive and calcium / vitamin D |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |